Topotecan (SKF104864): Deep-Dive on Pharmacology and Transla
2026-04-20
Explore the advanced pharmacology and translational research value of Topotecan (SKF104864) for cancer research. This article synthesizes rigorous evidence, protocol specifics, and cross-study insights to guide assay design and innovation.
Distinct Apoptosis Pathways in BMECs Induced by Candida krus
2026-04-20
This study reveals that the yeast and hypha phases of Candida krusei trigger apoptosis in bovine mammary epithelial cells (BMECs) through different signaling pathways. The findings provide mechanistic insight into fungal mastitis and inform targeted approaches for apoptosis modulation in infection models.
Stiripentol: Redefining LDH Inhibition in Epilepsy and Immun
2026-04-19
This thought-leadership article examines Stiripentol, a novel noncompetitive LDH inhibitor from APExBIO, as a transformative research tool for translational investigators. Drawing on recent insights into lactate metabolism, epigenetic regulation, and immune modulation, we provide a mechanistic rationale for targeting the astrocyte-neuron lactate shuttle, review experimental validation in preclinical models, and deliver actionable protocol guidance. By bridging the latest findings in oncology and epilepsy, this piece charts the next frontier for metabolic intervention in disease.
RESTRICT-seq Reveals Epigenetic Dependencies in SCC Resistan
2026-04-18
The RESTRICT-seq platform introduces a time-gated CRISPR screening method, enabling precise interrogation of epigenetic vulnerabilities underlying squamous cell carcinoma (SCC) resistance. This approach uncovers novel histone acetyltransferase dependencies, offering actionable insights for epigenetic drug targeting in cancer biology.
Deep Learning-Based Cardiotoxicity Detection in iPSC-CMs
2026-04-17
This study demonstrates a deep learning approach for detecting cardiotoxicity using high-content imaging of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). The method enables early identification of drug-induced cardiac risks, offering a scalable solution for phenotypic screening in drug development.
Necrosulfonamide: MLKL Inhibitor for Necroptosis Pathway Res
2026-04-16
Necrosulfonamide (NSA) is a highly selective inhibitor of MLKL, central to necroptosis research. NSA demonstrates nanomolar potency and pathway specificity, enabling precise dissection of necroptotic cell death without affecting apoptosis or non-target mechanisms.
Semi-Automated Screening of Fast-Dissociating Antibodies for
2026-04-15
Miyoshi et al. introduce a semi-automated single-molecule microscopy assay to identify fast-dissociating, highly specific monoclonal antibodies directly from hybridoma cultures. This innovation enables new approaches for multiplexed super-resolution imaging and dynamic studies of protein turnover, with direct applications to widely used epitope tags such as the V5 tag.
NBC19: Advancing NLRP3 Inflammasome Inhibition in Translatio
2026-04-14
This thought-leadership article explores how NBC19, a potent NLRP3 inflammasome inhibitor from APExBIO, empowers translational researchers to dissect and modulate inflammatory signaling. Moving beyond standard product overviews, it contextualizes NBC19 within recent mechanistic discoveries—such as lactate-driven HMGB1 release—and offers actionable strategies for experimental design, protocol optimization, and translational relevance. The discussion integrates key numeric evidence, current workflow recommendations, and competitive landscape analysis, positioning NBC19 as a next-generation tool for inflammation research.
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Guidance
2026-04-13
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody addresses the need for sensitive and specific detection of goat immunoglobulins across ICC/IF, IHC, flow cytometry, and ELISA. It is best suited for workflows requiring fluorescence-based signal amplification in immunodetection. Researchers should avoid use in domains or sample types not validated in the product dossier, such as non-goat primary antibody detection or multiplexing with dyes overlapping Cy3 spectra.
(-)-JQ1: Defining Rigor in Translational BET Bromodomain Res
2026-04-12
This thought-leadership article explores the mechanistic rationale, experimental best practices, and translational implications of deploying (-)-JQ1—the inactive JQ1 stereoisomer—as the gold-standard negative control in BET bromodomain inhibitor studies. Building on recent evidence in pancreatic ductal adenocarcinoma (PDA) and integrating insights from leading content, we provide strategic guidance for translational researchers to elevate specificity, reproducibility, and innovation in epigenetics and cancer biology.
Verapamil HCl: Applied L-type Calcium Channel Blocker in Res
2026-04-12
Verapamil HCl is a versatile L-type calcium channel blocker enabling precise control of calcium signaling, apoptosis induction, and inflammation attenuation in advanced disease models. This article delivers actionable guidance on experimental deployment, protocol optimization, and troubleshooting, rooted in benchmarked findings and translational workflows.
Cisplatin (CDDP): Optimizing Tumor Growth Inhibition Workflo
2026-04-11
Harness the full potential of Cisplatin (CDDP) in advanced cancer research with protocol enhancements and troubleshooting tips that boost reproducibility and mechanistic insight. This guide demystifies applied use-cases, leveraging recent breakthroughs to refine apoptosis assays and xenograft models.
PCI-32765 (Ibrutinib): Optimizing BTK Inhibition in B-Cell R
2026-04-11
PCI-32765 (Ibrutinib) empowers researchers to dissect B-cell receptor signaling and model B-cell malignancies with nanomolar precision. This guide highlights advanced protocols, troubleshooting strategies, and the latest cross-domain insights that leverage APExBIO’s trusted compound for reproducible, translational outcomes.
Levofloxacin (SKU B1959): Scenario-Driven Solutions for A...
2026-04-10
This article delivers practical, scenario-based guidance for using Levofloxacin (SKU B1959) in cell viability, proliferation, and bone metabolism assays. Drawing on peer-reviewed data and recent resistance trends, it highlights validated protocols, experimental reliability, and actionable vendor comparisons for biomedical researchers and lab technicians.
Nonivamide: TRPV1 Agonist for Cancer and Neuroimmune Rese...
2026-04-09
Nonivamide, a capsaicin analog and TRPV1 receptor agonist, empowers researchers to dissect cancer cell apoptosis and neuroimmune signaling with high specificity and reproducibility. This in-depth guide details optimized experimental workflows, advanced applications, and troubleshooting strategies, positioning Nonivamide as a premier anti-proliferative agent and mitochondrial apoptosis pathway activator for translational oncology and inflammation studies.
467 records 22/32 page Previous Next First page 上5页 2122232425 下5页 Last page